| #1 | | | Gurgaon, India | | 19+ years | Immunotherapy with Keytruda (Pembolizumab) | — | — | Joint Commission International , Indian National Hospital Accreditation Board |
| #2 | | | Bengaluru, India | | 35+ years | Immunotherapy with Keytruda (Pembrolizumab), chemotherapy or radiotherapy if required after evaluation | Patients requiring detailed clinical evaluation and repeat biopsy | Offers immunotherapy with Keytruda and comprehensive evaluation process. The hospital is JCI accredited, has a 4.7 rating from patient reviews, and serves over 2 million patients annually. | International Organization for Standardization, Indian National Accreditation Board for Testing and Calibration Laboratories |
| #3 | | | Delhi, India | | 43+ years | Immunotherapy with Keytruda (Pembolizumab) | — | — | Joint Commission International , The Week magazine ranking |
| #4 | | | Gurgaon, India | | 14+ years | Immunotherapy with Keytruda (Pembolizumab) | — | — | World's Best Smart Hospitals 2023 by Newsweek |
| #5 | | | Delhi, India | | 67+ years | Immunotherapy with Keytruda (Pembolizumab) | — | — | Joint Commission International , Indian National Accreditation Board for Testing and Calibration Laboratories |
| #6 | | | Panaji, India | | — | Immunotherapy with Keytruda (Pembolizumab) | — | — | Indian National Hospital Accreditation Board |
| #7 | | | Nashik, India | | 30+ years | Immunotherapy with Keytruda (Pembolizumab) | — | — | Indian National Accreditation Board for Testing and Calibration Laboratories, Indian National Hospital Accreditation Board |